Literature DB >> 18382877

Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.

Suk-Joon Chang1, Hee-Sug Ryu, Ki-Hong Chang, Seung-Chul Yoo, Jong-Hyuck Yoon.   

Abstract

BACKGROUND: The impact of micropapillary histology on survival in patients with serous borderline ovarian tumors is not established. The purpose of this study was to evaluate the significance and influence of micropapillary pattern on clinical outcome of patients with serous borderline ovarian tumors.
METHODS: Eighty-five patients who underwent surgery and were diagnosed with serous borderline ovarian tumors were retrospectively studied. Among these patients, 18 patients showed micropapillary pattern on histologic examination, while the remaining 67 patients did not. The significance of the presence of micropapillary pattern and relationship with various clinicopathologic findings and progression-free survival were evaluated by statistical analysis.
RESULTS: No differences with regard to age, parity, body mass index, pretreatment CA-125 level, tumor size, bilaterality, and the duration of follow-up were observed between the two groups, but there was a significant difference in terms of FIGO stage (p<0.001), invasive implants (p=0.004), performing lymphadenectomy (p=0.009), operation time (p=0.003), estimated blood loss (p<0.001), residual disease>1 cm (p=0.001), adjuvant chemotherapy (p<0.001), and the length of hospital stay (p=0.013). Progression-free survival was found to be significantly decreased in patients with invasive implants (HR, 5.06; p=0.025) and micropapillary pattern (HR, 4.20; p=0.056) on multivariate analysis.
CONCLUSIONS: Micropapillary serous borderline ovarian tumors were associated with a more aggressive clinical course compared with typical serous borderline ovarian tumor. The presence of invasive implants and micropapillary pattern were significant prognostic factors in patients with serous borderline ovarian tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18382877     DOI: 10.1080/00016340801995640

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

1.  Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?

Authors:  Mario M Leitao
Journal:  Oncologist       Date:  2011-01-27

2.  Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.

Authors:  Carrie C Lubitz; Konstantinos P Economopoulos; Amanda C Pawlak; Kerry Lynch; Dora Dias-Santagata; William C Faquin; Peter M Sadow
Journal:  Thyroid       Date:  2014-03-06       Impact factor: 6.568

Review 3.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

4.  Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.

Authors:  Russell Vang; Charlotte G Hannibal; Jette Junge; Kirsten Frederiksen; Susanne K Kjaer; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

5.  Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.

Authors:  Tayfun Güngör; Metin Kaba; Eralp Başer; Hakan Yalçın; Hatice Bayramoğlu; Mustafa Beşli
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

Review 6.  The challenging management of borderline ovarian tumors (BOTs) in women of childbearing age.

Authors:  Luigi Della Corte; Antonio Mercorio; Paolo Serafino; Francesco Viciglione; Mario Palumbo; Maria Chiara De Angelis; Maria Borgo; Cira Buonfantino; Marina Tesorone; Giuseppe Bifulco; Pierluigi Giampaolino
Journal:  Front Surg       Date:  2022-08-23

7.  Parameters of blood count and tumor markers in patients with borderline ovarian tumors: a retrospective analysis and relation to staging.

Authors:  Rosekeila Simões Nomelini; Taísa Morete da Silva; Beatriz Martins Tavares Murta; Eddie Fernando Candido Murta
Journal:  ISRN Oncol       Date:  2012-04-17

8.  Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany.

Authors:  A Coumbos; J Sehouli; R Chekerov; D Schaedel; G Oskay-Oezcelik; W Lichtenegger; W Kuehn
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

Review 9.  The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives.

Authors:  Yu Sun; Juan Xu; Xuemei Jia
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.